Table 2.
Biomaterials used in hydrogels to deliver nonviral vectors.
Nonviral vectors | Materials | Systems | Genes | Release profiles | Efficacy | Targets | References |
---|---|---|---|---|---|---|---|
Naked DNA | PLGA | Injectable implant | luc | Sustained release for 2 months | Sustained expression, tolerance in vivo | CV1 cells, s.c. injection (mouse) | [66] |
pNIPAAm | pNIPAAm-co-AAc nanogel | luc | Not reported | Effective internalization | hMSCs | [67] | |
GFP | s.c. injection (mouse) | ||||||
| |||||||
Lipoplexes | PEG | Hydrogel modified with affinity peptides | luc | ~59%, 75%, and 80% in K8, K4, and RGD hydrogels for 6 days | 5- to 15-fold increased transfection with K8 and K4 hydrogels | HT1080 cells | [68] |
GFP, luc | |||||||
Fibrin | Microspheres in fibrin gel | eNOS | 100% release by 24 h from fibrin gels, slower release with microspheres | Enhanced angiogenesis | Ear ulcer model (rabbit) | [69] | |
| |||||||
Polyplexes | PEG | OPF porous scaffold | SOX trio | Not reported | Combination of RUNX2 and SOX trio DNA improved healing relative to empty hydrogels | Osteochondral defect (rat) | [41] |
RUNX2 | |||||||
SEAP | Not free diffusion of polyplexes in hydrogel | Reduced polyplexes aggregation, effective gene transfer | NIH 3T3 cells, chorionic chick embryo | [70] | |||
Hydrogel with nanosized micelles | luc | Not reported | Higher transfection efficiency in the presence of micelles | hMSCs | [71] | ||
Fibrin | lacZ | <1% released at 3 days | Effective gene transfer | Chorionic chick embryo | [72] | ||
VEGF | |||||||
SEAP | Not free diffusion of polyplexes in hydrogel | Reduced polyplexes aggregation, effective gene transfer | NIH 3T3 cells, chorionic chick embryo | [70] | |||
HA | Porous HA hydrogel | Gluc | Sustained release for 14 days in the presence of collagenase I treatment (<25% release) | Reduced aggregation of polyplexes | HEK293T cell | [73] | |
SEAP | |||||||
Fibrin hydrogel | lacZ | <1% released at 3 days | Effective gene transfer | Chorionic chick embryo | [72] | ||
VEGF | |||||||
Microporous HA hydrogel | Gluc | Controlled release for 10 days | Sustained transgene expression for up to 10 days | mMSCs | [74] | ||
MMP-degradable HA hydrogel | Gluc | Stiffer hydrogels resulted in lower release rates in buffer, collagenase I, and hyaluronidase | Higher N/P ratios lead to higher gene transfer efficiency but also higher toxicity | mMSCs | [75] | ||
SEAP | Not free diffusion of polyplexes in hydrogel | Reduced polyplexes aggregation, effective gene transfer | NIH 3T3 cells, chorionic chick embryo | [70] |
PLGA: poly(lactic/glycolic acid); pNIPAAm-co-AAc: poly(N-isopropylacrylamide-co-acrylic acid); PEG: polyethylene glycol; HA: hyaluronic acid; OPF: oligo(poly(ethylene glycol) fumarate); MMP: matrix metalloproteinase; luc: firefly luciferase; GFP: green fluorescent protein; eNOS: endothelial nitric oxide synthase; SOX: sex determining region Y-box; RUNX2: runt-related transcription factor 2; lacZ: E. coliβ-galactosidase; VEGF: vascular endothelial growth factor; Gluc: Gaussia luciferase; SEAP: secreted embryonic alkaline phosphatase; K8: GCGYGK8 peptide; K4: GCGK4 peptide; RGD: Arg-Gly-Asp; N/P: polyplex nitrogen-to-phosphate ratio; s.c.: subcutaneous; hMSCs: human mesenchymal stem cells; mMSCs: mouse mesenchymal stem cells.